Literature DB >> 10681596

Membrane targeting and cytoplasmic sequestration in the spatiotemporal localization of human protein kinase C alpha.

A Vallentin1, C Prévostel, T Fauquier, X Bonnefont, D Joubert.   

Abstract

In order to map the molecular determinants that dictate the subcellular localization of human protein kinase C alpha (hPKCalpha), full-length and deletion mutants of hPKCalpha were tagged with the green fluorescent protein (GFP) and transiently expressed in GH3B6 cells. We found that upon thyrotropin-releasing hormone (TRH) or phorbol 12-myristate 13-acetate stimulation, hPKCalpha-GFP was localized exclusively in regions of cell-cell contacts. Surprisingly, PKCalpha failed to translocate in single cells despite the presence of TRH receptors, as attested by the TRH-induced rise in intracellular calcium concentration in these cells. TRH-stimulated translocation of hPKCalpha-GFP from the cytoplasm to cell-cell contacts was a biphasic process: a fast (measured in seconds) and transient phase, followed by a slower (approximately 1 hour) and long lasting phase. The latter and the translocation induced by phorbol 12-myristate 13-acetate absolutely required the N-terminal V1 region. In contrast to the full-length hPKCalpha, the N-terminal regulatory domain alone or associated with the V3 hinge region was spontaneously and uniformly localized at the plasma membrane of single and apposed cells. However, treatment with the calcium chelator BAPTA/AM induced a differential cytoplasmic/nuclear redistribution of the regulatory domain, depending on its association with V3, which suggests the existence of a mechanism controlling the cytoplasmic sequestration of inactive hPKCalpha and involving the V3 region. By using other deletion mutants, we were able to map the sequence required for this sequestration to the C2+V3 regions. This work points to the existence of a complex interplay between membrane targeting and cytoplasmic sequestration in the control of the spatiotemporal localization of hPKCalpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681596     DOI: 10.1074/jbc.275.8.6014

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The catalytic domain limits the translocation of protein kinase C alpha in response to increases in Ca2+ and diacylglycerol.

Authors:  Arathi Raghunath; Mia Ling; Christer Larsson
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  The ATP-dependent membrane localization of protein kinase Calpha is regulated by Ca2+ influx and phosphatidylinositol 4,5-bisphosphate in differentiated PC12 cells.

Authors:  Consuelo Marín-Vicente; Juan C Gómez-Fernández; Senena Corbalán-García
Journal:  Mol Biol Cell       Date:  2005-04-06       Impact factor: 4.138

3.  A single point mutation in the V3 region affects protein kinase Calpha targeting and accumulation at cell-cell contacts.

Authors:  A Vallentin; T C Lo; D Joubert
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  A spatiotemporally coordinated cascade of protein kinase C activation controls isoform-selective translocation.

Authors:  Alejandra Collazos; Barthélémy Diouf; Nathalie C Guérineau; Corinne Quittau-Prévostel; Marion Peter; Fanny Coudane; Frédéric Hollande; Dominique Joubert
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Role for PKCβ in enhanced endothelin-1-induced pulmonary vasoconstrictor reactivity following intermittent hypoxia.

Authors:  Jessica B Snow; Laura V Gonzalez Bosc; Nancy L Kanagy; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-29       Impact factor: 5.464

6.  Positive feedback of protein kinase C proteolytic activation during apoptosis.

Authors:  Sabrina Leverrier; Alice Vallentin; Dominique Joubert
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

7.  Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis.

Authors:  Maddy Parsons; Melanie D Keppler; Adam Kline; Anthea Messent; Martin J Humphries; Ruth Gilchrist; Ian R Hart; Corinne Quittau-Prevostel; William E Hughes; Peter J Parker; Tony Ng
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

8.  A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas.

Authors:  Shai Rosenberg; Iva Simeonova; Franck Bielle; Maite Verreault; Bertille Bance; Isabelle Le Roux; Mailys Daniau; Arun Nadaradjane; Vincent Gleize; Sophie Paris; Yannick Marie; Marine Giry; Marc Polivka; Dominique Figarella-Branger; Marie-Hélène Aubriot-Lorton; Chiara Villa; Alexandre Vasiljevic; Emmanuèle Lechapt-Zalcman; Michel Kalamarides; Ariane Sharif; Karima Mokhtari; Stefano Maria Pagnotta; Antonio Iavarone; Anna Lasorella; Emmanuelle Huillard; Marc Sanson
Journal:  Nat Commun       Date:  2018-06-18       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.